These opposing results were explained by the relocation of P-cadherin, because patients—where this protein concentrates in the cytoplasm—exhibited a shorter cancer-specific survival (CSS) rate than those where the expression of P-cadherin was circumscribed to the cell membrane. The gene discussed is CDH3; the disease is cancer.